Erste Asset Management’s Ocular Therapeutix OCUL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$814K	Hold	110,000	–	–	0.01%	463
2025 Q4	$1.35M	Sell	110,000 -125,800	-53%	-$1.53M	0.01%	403
2025 Q3	$2.95M	Hold	235,800	–	–	0.03%	310
2025 Q2	$2.17M	Hold	235,800	–	–	0.02%	387
2025 Q1	$1.79M	Hold	235,800	–	–	0.02%	320
2024 Q4	$1.99M	Hold	235,800	–	–	0.02%	325
2024 Q3	$2.05M	Hold	235,800	–	–	0.02%	319
2024 Q2	$1.59M	Hold	235,800	–	–	0.02%	327
2024 Q1	$2.2M	Hold	235,800	–	–	0.03%	292
2023 Q4	$1.07M	Buy	235,800 +77,000	+48%	+$228K	0.02%	368
2023 Q3	$507K	Hold	158,800	–	–	0.01%	405
2023 Q2	$805K	Hold	158,800	–	–	0.01%	378
2023 Q1	$819K	Hold	158,800	–	–	0.02%	384
2022 Q4	$445K	Buy	158,800 +63,000	+66%	+$209K	0.01%	435
2022 Q3	$491K	Hold	95,800	–	–	0.01%	425
2022 Q2	$373K	Hold	95,800	–	–	0.01%	457
2022 Q1	$484K	Hold	95,800	–	–	0.01%	440
2021 Q4	$632K	Hold	95,800	–	–	0.01%	407
2021 Q3	$971K	Buy	95,800 +26,000	+37%	+$292K	0.02%	341
2021 Q2	$960K	Hold	69,800	–	–	0.02%	346
2021 Q1	$1.12M	Buy	69,800 +17,800	+34%	+$343K	0.03%	326
2020 Q4	$1.04M	Buy	+52,000	New	+$772K	0.03%	331